Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NLS Pharmaceutics ( (NLSP) ) has shared an update.
On August 21, 2025, NLS Pharmaceutics announced the rescheduling of its Extraordinary Shareholders’ Meeting to September 16, 2025, to allow more time for evaluating comments from the U.S. SEC regarding its pending merger with Kadimastem Ltd. This delay aims to ensure shareholders have the most complete information for decision-making, reflecting the company’s commitment to transparency and regulatory compliance.
More about NLS Pharmaceutics
NLS Pharmaceutics Ltd. is a pharmaceutical company based in Zurich, Switzerland, focusing on the development of therapeutics for the treatment of central nervous system disorders.
Average Trading Volume: 259,628
Technical Sentiment Signal: Sell
Current Market Cap: $9.46M
Find detailed analytics on NLSP stock on TipRanks’ Stock Analysis page.